In Vivo Gene Therapy Cures Infertility in Mice

Mice rendered infertile through ovary cell–targeting mutations gave birth to seemingly normal offspring through natural mating after a virus-based gene therapy was injected into their ovaries.

Written byDan Robitzski
| 2 min read
a white mouse huddles with several of her nine-day-old pups
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Within healthy ovaries, granulosa cells supply developing oocytes with nutrients and secrete hormones that regulate their further development. Without those cells’ support, oogenesis can’t occur, rendering an animal infertile. However, scientists at Kyoto University found a way to restore granulosa function in mice bred to have a granulosa-impairing mutation, according to research published April 27 in Cell Reports Medicine. They say the approach could someday lead to new infertility treatments for humans as well.

The experimental mice were bred to have silenced Kitl genes, which produce a molecule that mediates communication between oocytes and granulosa and fosters ovarian follicle development. In the absence of Kitl expression, oogenesis was prevented in female mice. Conceptually, developing a gene therapy to deliver a functional Kitl copy was simple, lead author and Kyoto University molecular geneticist Takashi Shinohara explains. However, figuring out a delivery mechanism that could actually reach the granulosa cells was difficult ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • black and white image of young man in sunglasses with trees in background

    Dan is an award-winning journalist based in Los Angeles who joined The Scientist as a reporter and editor in 2021. Ironically, Dan’s undergraduate degree and brief career in neuroscience inspired him to write about research rather than conduct it, culminating in him earning a master’s degree in science journalism from New York University in 2017. In 2018, an Undark feature Dan and colleagues began at NYU on a questionable drug approval decision at the FDA won first place in the student category of the Association of Health Care Journalists' Awards for Excellence in Health Care Journalism. Now, Dan writes and edits stories on all aspects of the life sciences for the online news desk, and he oversees the “The Literature” and “Modus Operandi” sections of the monthly TS Digest and quarterly print magazine. Read more of his work at danrobitzski.com.

    View Full Profile
Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo
Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery